David Cicilline actually said...

I think that regulatory reform and competition advocacy are very, very important.

You can't just do that and expect these healthcare pharma issues to be taken care of without funding those agencies.

I am tremendously encouraged to see bipartisan efforts to address these critical needs and to help improve access to affordable prescription...

We need to get that done immediately. That will add significant resources to the two agencies, plus the appropriations policy.